Greater effectiveness of daily iron supplementation scheme in infants

Catarina Machado Azeredo1, Rosângela Minardi Mitre Cotta, Luciana Ferreira da Rocha Sant'Ana

  • 1Universidade Federal de Viçosa, Viçosa, MG, Brasil.

Insights

Daily iron supplementation is more effective than weekly for preventing anemia in infants. The Brazilian Ministry of Health

Area of Science:

  • Pediatrics
  • Public Health
  • Nutritional Science

Background:

  • Iron deficiency anemia is a significant global health concern in infants.
  • Preventive iron supplementation is a key strategy to combat anemia.
  • Different supplementation schedules exist, with varying reported efficacies.

Purpose of the Study:

  • To compare the effectiveness of daily versus weekly iron supplementation in preventing anemia in non-anemic infants.
  • To evaluate the impact of different iron dosage schemes on hemoglobin levels and anemia prevalence.
  • To inform public health policies regarding infant iron supplementation.

Main Methods:

  • A prospective, quantitative intervention study was conducted in Brazil.
  • 103 non-anemic infants (6-18 months) were divided into daily (n=34) and weekly (n=69) iron supplementation groups.
  • Assessments included hemoglobin levels, anthropometry, diet, and socioeconomic factors over six months.

Main Results:

  • The daily supplementation group showed significantly higher mean hemoglobin levels (p=0.015) and lower anemia prevalence (p=0.04) after six months.
  • Supplementation time was the only factor influencing severe anemia (p=0.009).
  • No significant differences were found in adherence or side effects between groups.

Conclusions:

  • Daily iron supplementation, as recommended by the Brazilian Society of Pediatrics, is more effective in preventing infant anemia than the weekly scheme used by the Ministry of Health.
  • The current weekly iron dosage strategy requires review to improve anemia prevention in public health services.
  • Evidence supports optimizing iron supplementation protocols for vulnerable infant populations.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Environmental Influences on Intelligence01:29

Environmental Influences on Intelligence

Despite the strong genetic influence on traits like intelligence, environmental factors significantly shape outcomes. For example, while over 90% of height variation is due to genetic differences, environmental factors such as nutrition also have a notable impact. Similarly, for intelligence, changes in a child's surroundings can significantly alter their IQ. Research shows that enriched environments boost children's academic success and help them develop key cognitive skills. Children from...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...